(OR) Osisko Gold Ro - Overview
Stock: Royalties, Streams, Gold, Silver
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.72% |
| Yield on Cost 5y | 2.00% |
| Yield CAGR 5y | -1.49% |
| Payout Consistency | 95.8% |
| Payout Ratio | 30.4% |
| Risk 5d forecast | |
|---|---|
| Volatility | 53.5% |
| Relative Tail Risk | -0.42% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.91 |
| Alpha | 98.77 |
| Character TTM | |
|---|---|
| Beta | 0.220 |
| Beta Downside | -0.029 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.37% |
| CAGR/Max DD | 1.41 |
Description: OR Osisko Gold Ro January 09, 2026
OR Royalties Inc. (NYSE: OR) acquires and manages royalties, streams, and related interests in precious-metal projects worldwide, with its flagship asset being a 3-5% net smelter return (NSR) royalty on the Canadian Malartic complex – one of Canada’s largest gold mines producing roughly 700,000 oz of gold annually. The company also holds off-take options, royalty-stream financing rights, and exclusive participation rights in future financings, while maintaining a modest exploration program focused on gold, silver, and diamonds.
As of the most recent filing (Q4 2023), OR reported a market-cap of about US$1.2 billion and a royalty-derived cash flow yield of ~6.5%, which is relatively high for the sector given the low-leverage profile (net debt ≈ US$50 million). The royalty’s cash flows are tightly linked to gold price movements; a 10% rise in spot gold (currently ~US$1,950/oz) would be expected to lift annual royalty cash receipts by roughly 8% based on historical sensitivity analyses. Additionally, the broader gold sector benefits from persistent inflationary pressures and a low-interest-rate environment, both of which have historically supported gold demand and price stability.
For a deeper quantitative view, the ValueRay platform offers a granular breakdown of OR’s royalty exposure and cash-flow sensitivity, which can help you assess the trade-off between upside potential and downside risk.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 147.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -2.74 > 1.0 |
| NWC/Revenue: 48.80% < 20% (prev 24.20%; Δ 24.60% < -1%) |
| CFO/TA 0.10 > 3% & CFO 209.6m > Net Income 147.7m |
| Net Debt (-72.0m) to EBITDA (230.6m): -0.31 < 3 |
| Current Ratio: 4.37 > 1.5 & < 3 |
| Outstanding Shares: last quarter (189.5m) vs 12m ago 0.95% < -2% |
| Gross Margin: 82.07% > 18% (prev 0.83%; Δ 8125 % > 0.5%) |
| Asset Turnover: 13.85% > 50% (prev 14.33%; Δ -0.48% > 0%) |
| Interest Coverage Ratio: 37.73 > 6 (EBITDA TTM 230.6m / Interest Expense TTM 5.17m) |
Altman Z'' 10.00
| A: 0.06 (Total Current Assets 153.1m - Total Current Liabilities 35.0m) / Total Assets 2.11b |
| B: -0.20 (Retained Earnings -427.0m / Total Assets 2.11b) |
| C: 0.11 (EBIT TTM 195.0m / Avg Total Assets 1.75b) |
| D: 11.05 (Book Value of Equity 1.85b / Total Liabilities 167.8m) |
| Altman-Z'' Score: 12.06 = AAA |
Beneish M -3.17
| DSRI: 0.61 (Receivables 4.80m/6.44m, Revenue 242.0m/198.4m) |
| GMI: 1.01 (GM 82.07% / 82.67%) |
| AQI: 1.08 (AQ_t 0.18 / AQ_t-1 0.16) |
| SGI: 1.22 (Revenue 242.0m / 198.4m) |
| TATA: -0.03 (NI 147.7m - CFO 209.6m) / TA 2.11b) |
| Beneish M-Score: -3.17 (Cap -4..+1) = AA |
What is the price of OR shares?
Over the past week, the price has changed by +1.50%, over one month by +8.63%, over three months by +28.99% and over the past year by +105.00%.
Is OR a buy, sell or hold?
- StrongBuy: 4
- Buy: 6
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the OR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 46.3 | 15.5% |
| Analysts Target Price | 46.3 | 15.5% |
| ValueRay Target Price | 57.5 | 43.7% |
OR Fundamental Data Overview February 07, 2026
P/E Forward = 30.3951
P/S = 29.8358
P/B = 5.5298
Revenue TTM = 242.0m USD
EBIT TTM = 195.0m USD
EBITDA TTM = 230.6m USD
Long Term Debt = 93.9m USD (from longTermDebt, last fiscal year)
Short Term Debt = 1.74m USD (from shortTermDebt, last quarter)
Debt = 7.34m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -72.0m USD (from netDebt column, last quarter)
Enterprise Value = 7.13b USD (7.27b + Debt 7.34m - CCE 147.3m)
Interest Coverage Ratio = 37.73 (Ebit TTM 195.0m / Interest Expense TTM 5.17m)
EV/FCF = 63.11x (Enterprise Value 7.13b / FCF TTM 113.0m)
FCF Yield = 1.58% (FCF TTM 113.0m / Enterprise Value 7.13b)
FCF Margin = 46.67% (FCF TTM 113.0m / Revenue TTM 242.0m)
Net Margin = 61.04% (Net Income TTM 147.7m / Revenue TTM 242.0m)
Gross Margin = 82.07% ((Revenue TTM 242.0m - Cost of Revenue TTM 43.4m) / Revenue TTM)
Gross Margin QoQ = 82.51% (prev 83.15%)
Tobins Q-Ratio = 3.38 (Enterprise Value 7.13b / Total Assets 2.11b)
Interest Expense / Debt = 12.07% (Interest Expense 886.0k / Debt 7.34m)
Taxrate = 10.04% (9.24m / 92.1m)
NOPAT = 175.4m (EBIT 195.0m * (1 - 10.04%))
Current Ratio = 4.37 (Total Current Assets 153.1m / Total Current Liabilities 35.0m)
Debt / Equity = 0.00 (Debt 7.34m / totalStockholderEquity, last quarter 1.94b)
Debt / EBITDA = -0.31 (Net Debt -72.0m / EBITDA 230.6m)
Debt / FCF = -0.64 (Net Debt -72.0m / FCF TTM 113.0m)
Total Stockholder Equity = 1.41b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.45% (Net Income 147.7m / Total Assets 2.11b)
RoE = 10.49% (Net Income TTM 147.7m / Total Stockholder Equity 1.41b)
RoCE = 12.98% (EBIT 195.0m / Capital Employed (Equity 1.41b + L.T.Debt 93.9m))
RoIC = 13.26% (NOPAT 175.4m / Invested Capital 1.32b)
WACC = 6.73% (E(7.27b)/V(7.28b) * Re(6.73%) + D(7.34m)/V(7.28b) * Rd(12.07%) * (1-Tc(0.10)))
Discount Rate = 6.73% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 1.07%
[DCF Debug] Terminal Value 76.37% ; FCFF base≈112.6m ; Y1≈73.9m ; Y5≈33.7m
Fair Price DCF = 4.93 (EV 855.5m - Net Debt -72.0m = Equity 927.5m / Shares 188.0m; r=6.73% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 49.56 | EPS CAGR: 12.81% | SUE: -2.83 | # QB: 0
Revenue Correlation: 31.73 | Revenue CAGR: 9.67% | SUE: 2.96 | # QB: 1
EPS next Quarter (2026-03-31): EPS=0.35 | Chg30d=+0.060 | Revisions Net=+1 | Analysts=3
EPS next Year (2026-12-31): EPS=1.37 | Chg30d=+0.199 | Revisions Net=+4 | Growth EPS=+59.2% | Growth Revenue=+50.7%